Angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers vs. calcium channel blockers for 12,478 young hypertensive patients under 40 in 10-year follow-up

被引：0
|
作者：
Jo, S. H. [1 ]
Shim, H. S. [2 ]
Hong, J. Y. [1 ]
Kim, T. H. [2 ]
Cheon, D. Y. [1 ]
Kim, S. A. [1 ]
机构：
[1] Hallym Univ, Sacred Heart Hosp, Anyang, South Korea
[2] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus
    Kawada, Tomoyuki
    CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 4 - 4
  • [22] Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis
    Jenny I. Shen
    Anjali B. Saxena
    Maria E. Montez-Rath
    Lynn Leng
    Tara I. Chang
    Wolfgang C. Winkelmayer
    Journal of Nephrology, 2017, 30 : 281 - 288
  • [23] Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis
    Shen, Jenny I.
    Saxena, Anjali B.
    Montez-Rath, Maria E.
    Leng, Lynn
    Chang, Tara I.
    Winkelmayer, Wolfgang C.
    JOURNAL OF NEPHROLOGY, 2017, 30 (02) : 281 - 288
  • [24] Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
    Hsiao, Fu-Chih
    Tung, Ying-Chang
    Chou, Shing-Hsien
    Wu, Lung-Sheng
    Lin, Chia-Pin
    Wang, Chun-Li
    Lin, Yu-Sheng
    Chang, Chee-Jen
    Chu, Pao-Hsien
    MEDICINE, 2015, 94 (51)
  • [25] Angiotensin-converting enzyme inhibitors are comparable to angiotensin II receptor blockers in the primary prevention of myocardial infarction in hypertensive patients
    Baer, JT
    Sauer, WH
    Berlin, JA
    Kimmel, SE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 531A - 531A
  • [26] Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19
    Covino, Marcello
    De Matteis, Giuseppe
    Burzo, Maria Livia
    Santoro, Michele
    Fuorlo, Mariella
    Sabia, Luca
    Sandroni, Claudio
    Gasbarrini, Antonio
    Franceschi, Francesco
    Gambassi, Giovanni
    INTERNAL MEDICINE JOURNAL, 2020, 50 (12) : 1483 - 1491
  • [27] Has the use of angiotensin converting enzyme inhibitors and calcium channel blockers improved the outcome for hypertensive patients?
    Gifford, RW
    AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (03) : S9 - S12
  • [28] Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors
    Ong, HT
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16): : 2068 - 2068
  • [29] No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers
    Gilbert, Cameron J.
    Gomes, Tara
    Mamdani, Muhammad M.
    Hellings, Chelsea
    Yao, Zhan
    Garg, Amit X.
    Wald, Ron
    Harel, Ziv
    Juurlink, David N.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (05) : 586 - 591
  • [30] Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction
    Lee, Jae-Geun
    Joo, Seung-Jae
    Kim, Song-Yi
    Choi, Joon-Hyouk
    Boo, Ki Yung
    Hwang, Jin-Yong
    Hur, Seung-Ho
    Jeong, Myung Ho
    PLOS ONE, 2023, 18 (03):
12345